• Neurelis announces FDA approval for seizure rescue treatment VALTOCO®

    13 January 2020
    Download

  • Arcutis Announces ARQ-154 Program for Seborrheic Dermatitis and Enrollment of First Patient in Phase 2 Proof of Concept Clinical Trial

    5 December 2019
    Download

  • Der Bedarf der Pharmakonzerne nach neuen Medikamenten ist ungestillt - Interview Dr. Andreas Wicki

    6 November 2019
    Download

  • Arcutis Biotherapeutics Announces Positive End-of-Phase 2 Meeting with FDA and Planned Initiation of Phase 3 Program for ARQ-151 for Plaque Psoriasis

    24 October 2019
    Download

  • Arcutis Announces the Completion of $94.5 million Series C Financing

    21 October 2019
    Download

  • UCB Agrees to Acquire Ra Pharmaceuticals: Joining Forces to Improve Treatment Options for People Living With Myasthenia Gravis and Other Rare Diseases

    10 October 2019
    Download

  • Viela Bio Announces Closing of Initial Public Offering and Full Exercise of Underwriters? Option to Purchase Additional Shares

    7 October 2019
    Download

  • Swixx signs deal to represent Alexion in Russia & announces opening of Russian operations and Swixx appointed distributor for Alexion Russia

    1 October 2019
    Download

  • Adrenomed completes full enrollment with 300 patients in AdrenOSS-2 trial with Adrecizumab in septic shock

    26 September 2019
    Download

  • Investing in biotechnology - a lucrative approach

    1 September 2019
    Download

  • Investieren in die Biotechnologie – ein aktiver Ansatz zahlt sich aus

    1 September 2019
    Download

  • U.S. FDA accepts for review Viela Bio's first BLA filing

    27 August 2019
    Download

  • Harmony Biosciences Announces FDA Approval of WAKIX (pitolisant), a First-In-Class Medication for the Treatment of Excessive Daytime Sleepiness in Adult Patients with Narcolepsy

    15 August 2019
    Download

  • Interview with Andreas Wicki

    14 August 2019
    Download

  • Interview with Ivo Staijen

    17 July 2019
    Download

  • SpringWorks Therapeutics Announces Global Clinical Collaboration with GlaxoSmithKline to Evaluate Nirogacestat in Combination with Belantamab Mafodotin in Patients with Relapsed or Refractory Multiple Myeloma

    27 June 2019
    Download

  • 1mg to accelerate investments in Growth, Supply Chain & AI/ML driven personalized care

    27 June 2019
    Download

  • Viela Bio Closes $75 Million Series B Financing

    17 June 2019
    Download

  • Corvidia Therapeutics Initiates Phase 2b Dose-Finding Study for Ziltivekimab

    13 June 2019
    Download

  • SpringWorks Therapeutics Announces FDA Fast Track Designation for PD-0325901 for the Treatment of a Severe Form of Neurofibromatosis Type 1

    3 June 2019
    Download

  • Biotech-Unternehmen schwimmen im Geld

    25 May 2019
    Download

  • «Ungebremste Innovationskraft»

    1 May 2019
    Download

  • Unbridled Capacity for Innovation

    1 May 2019
    Download

  • Forbius: First Patient Dosed in a Phase 1b Myelofibrosis Trial of AVID200, a Novel TGF-beta 1 & 3 Inhibitor

    24 April 2019
    Download

  • Arrakis Therapeutics Raises $75M Series B To Develop Small-Molecule Medicines Targeting RNA

    18 April 2019
    Download
    • More news